Invero Pharma LLC announces it has acquired the assets and intellectual property of Neuroprotexeon Inc. The assets include the rights to develop and commercialize XENEX® (xenon gas and device for inhalation) as a potent neuro-protectant with an exceptional safety profile entering Phase 3 clinical studies.
Read the full article: Invero Pharma LLC Acquires Assets of Neuroprotexeon, Inc //
Source: https://www.prweb.com/releases/invero_pharma_llc_acquires_assets_of_neuroprotexeon_inc/prweb18042338.htm